MRD-driven addition of ibrutinib to venetoclax for CLL VJHemOnc – Video Journal of Hematology & HemOnc 2:36 3 years ago 115 Далее Скачать
Achieving undetectable MRD with ibrutinib plus venetoclax for CLL VJHemOnc – Video Journal of Hematology & HemOnc 1:53 3 years ago 219 Далее Скачать
Driver mutations predicting clinical outcomes upon MRD-guided venetoclax plus ibrutinib in R/R CLL VJHemOnc – Video Journal of Hematology & HemOnc 1:50 4 days ago 34 Далее Скачать
Outcomes in high-risk CLL patients following fixed-duration treatment with ibrutinib plus venetoclax VJHemOnc – Video Journal of Hematology & HemOnc 2:43 1 year ago 621 Далее Скачать
UK NCRI FLAIR trial: ibrutinib + venetoclax with MRD-directed duration of treatment in CLL VJHemOnc – Video Journal of Hematology & HemOnc 2:17 10 months ago 212 Далее Скачать
IMPROVE: 33-month follow-up of MRD-driven therapy in CLL VJHemOnc – Video Journal of Hematology & HemOnc 4:11 3 years ago 90 Далее Скачать
MRD outcomes from GLOW: venetoclax and ibrutinib in CLL VJHemOnc – Video Journal of Hematology & HemOnc 3:09 3 years ago 188 Далее Скачать
ASH CLL highlights: ibrutinib-venetoclax combination & undetectable MRD in IGHV-mutated patients VJHemOnc – Video Journal of Hematology & HemOnc 1:47 2 years ago 536 Далее Скачать
First-line ibrutinib and venetoclax in CLL VJHemOnc – Video Journal of Hematology & HemOnc 2:18 2 years ago 350 Далее Скачать
Update on venetoclax for CLL: How low can you go (MRD)? HMP Education 21:50 6 years ago 3 062 Далее Скачать
FLAIR trial: improved outcomes with MRD-guided ibrutinib plus venetoclax in CLL compared to FCR VJHemOnc – Video Journal of Hematology & HemOnc 3:00 1 year ago 365 Далее Скачать
Interim analysis of the FLAIR study: efficacy of ibrutinib plus venetoclax in IgHV unmutated CLL VJHemOnc – Video Journal of Hematology & HemOnc 1:23 1 year ago 328 Далее Скачать
HOVON 141/VISION trial update: MRD-guided venetoclax + ibrutinib treatment for R/R CLL VJHemOnc – Video Journal of Hematology & HemOnc 4:21 1 year ago 185 Далее Скачать
AVO achieves high rates of undetectable MRD in CLL VJHemOnc – Video Journal of Hematology & HemOnc 3:29 3 years ago 331 Далее Скачать
A "chemo-sparing" MRD-driven strategy for CLL VJHemOnc – Video Journal of Hematology & HemOnc 1:47 6 years ago 162 Далее Скачать
Ibrutinib + Venetoclax for Chronic Lymphocytic Leukemia (CLL) Treatment - Dr. Bill Wierda ASH 2022 CLL Society 6:39 1 year ago 279 Далее Скачать
Ibrutinib plus Venetoclax for first-line treatment of chronic lymphocytic leukaemia ecancer 6:55 3 years ago 377 Далее Скачать
MRD determinations in venetoclax treatment of CLL VJHemOnc – Video Journal of Hematology & HemOnc 2:35 5 years ago 302 Далее Скачать
Overcoming resistance to CAR-T therapy in CLL with ibrutinib & venetoclax VJHemOnc – Video Journal of Hematology & HemOnc 2:17 2 years ago 239 Далее Скачать
